×

    Cite This Article

    1.Al-Zahrani NS, Patel AA, El-Gamal B, Ellatif MA, Nasif KA, Abd Elrouf MB, et al. Drug Repurposing Revealed Abemaciclib and Palbociclib as Inhibitor of Phosphodiesterase-5 (PDE5) in Cancer-Associated Fibroblasts Paving the Way for the Treatment of Breast Cancer. Indian Journal of Pharmaceutical Education and Research [Internet]. 2025 May 16;59(3):1221–30. Available from: http://dx.doi.org/10.5530/ijper.20251022